NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has priced three series of senior notes totaling $2.2 billion in aggregate.
The firm is offering $300 million aggregate principal amount of 2.05 percent senior notes due 2014; $900 million aggregate principal amount of 3.2 percent senior notes due 2016; and $1 billion aggregate principal amount of 4.5 percent senior notes due 2021.
It expects to close the offering on Feb. 22, and said that the notes will pay interest on a semi-annual basis.
Thermo Fisher will use the proceeds to pay for its $2.1 billion acquisition of Dionex, which was announced in December.